Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention
Jennifer Y. Xie(Arkansas State University), Frank Porreca(University of Arizona), Hugh Rosen(La Jolla Institute for Immunology), Pablo Hernández(University of Arizona), John M. Streicher(University of Arizona), Nathan Eyde(University of Arizona), Milena De Felice(University of Sheffield), Michael H. Ossipov(University of Arizona), David W. Dodick(New York Academy of Medicine), Tamara King(University of New England), Justin LaVigne(Purdue University West Lafayette), Ed Roberts(Cancer Research UK Scotland Institute), Edita Navratilova(University of Arizona), Naomi Goshima(University of Arizona), Bethany Remeniuk(University of Arizona), Caroline Machado Kopruszinski(Universidade Federal do Paraná), Xu Yue(University of Arizona)
Cited by 86
Related Papers
Central modulation of pain
|Journal of Clinical Investigation|2010|1.1k
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease
|Annals of Neurology|1999|890
Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate
|Journal of Biological Chemistry|2004|621
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485